Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C C Benz

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
Vitamins and Hormones|October 19, 2000
Liposome targeting to tumors using vitamin and growth factor receptorsD C Drummond, K Hong, J W Park, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Pharmacokinetics of toremifene and its metabolites in patients with advanced breast cancerV J Wiebe, C C Benz, I Shemano, et al.
Breast Cancer Research and Treatment|January 1, 1993
Human breast tumors containing non-DNA-binding immunoreactive (67 kDa) estrogen receptorP A Montgomery, G K Scott, M C Luce, et al.
Breast Disease|February 3, 2005
Emerging antibody-based HER2 (ErbB-2/neu) therapeuticsW C Krauss, J W Park, D B Kirpotin, et al.
Oncogene|May 28, 2008
Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cellsD Bhaumik, G K Scott, S Schokrpur, et al.
Gene|November 4, 1994
Inhibition of transcription factor binding to the HER2 promoter by triplex-forming oligodeoxyribonucleotidesS B Noonberg, G K Scott, C A Hunt, et al.
Nucleic Acids Research|July 25, 1994
In vivo generation of highly abundant sequence-specific oligonucleotides for antisense and triplex gene regulationS B Noonberg, G K Scott, M R Garovoy, et al.
Cancer Letters|February 12, 1998
Anti-HER2 immunoliposomes for targeted therapy of human tumorsJ W Park, K Hong, D B Kirpotin, et al.
Molecular and Cellular Endocrinology|February 18, 1999
Oxidant stress impaired DNA-binding of estrogen receptor from human breast cancerX Liang, B Lu, G K Scott, et al.
The Journal of Biological Chemistry|August 5, 1994
Binding of an ETS-related protein within the DNase I hypersensitive site of the HER2/neu promoter in human breast cancer cellsG K Scott, J C Daniel, X Xiong, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Vitamins and Hormones|October 19, 2000
Liposome targeting to tumors using vitamin and growth factor receptorsD C Drummond, K Hong, J W Park, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Pharmacokinetics of toremifene and its metabolites in patients with advanced breast cancerV J Wiebe, C C Benz, I Shemano, et al.
Breast Cancer Research and Treatment|January 1, 1993
Human breast tumors containing non-DNA-binding immunoreactive (67 kDa) estrogen receptorP A Montgomery, G K Scott, M C Luce, et al.
Breast Disease|February 3, 2005
Emerging antibody-based HER2 (ErbB-2/neu) therapeuticsW C Krauss, J W Park, D B Kirpotin, et al.
Oncogene|May 28, 2008
Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cellsD Bhaumik, G K Scott, S Schokrpur, et al.
Gene|November 4, 1994
Inhibition of transcription factor binding to the HER2 promoter by triplex-forming oligodeoxyribonucleotidesS B Noonberg, G K Scott, C A Hunt, et al.
Nucleic Acids Research|July 25, 1994
In vivo generation of highly abundant sequence-specific oligonucleotides for antisense and triplex gene regulationS B Noonberg, G K Scott, M R Garovoy, et al.
Cancer Letters|February 12, 1998
Anti-HER2 immunoliposomes for targeted therapy of human tumorsJ W Park, K Hong, D B Kirpotin, et al.
Molecular and Cellular Endocrinology|February 18, 1999
Oxidant stress impaired DNA-binding of estrogen receptor from human breast cancerX Liang, B Lu, G K Scott, et al.
The Journal of Biological Chemistry|August 5, 1994
Binding of an ETS-related protein within the DNase I hypersensitive site of the HER2/neu promoter in human breast cancer cellsG K Scott, J C Daniel, X Xiong, et al.
Pageof 8